# Syntarga

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/syntarga-b-v

- Industry: Pharmaceuticals
- Headquarters: Netherlands
- Website: www.syntarga.com
- Latest round: Series A (Apr 15, 2005)
- Investors on record: 2

## About

Syntarga B.V. is a Netherlands-based technology company delivering innovative solutions for operational efficiency across multiple sectors. Their expertise enhances business processes, particularly in logistics, manufacturing, and healthcare.Syntarga B.V. specializes in technological solutions that optimize business operations. The company underwent a significant transition when it was sold to Synthon B.V. on June 28, 2011. It is headquartered in the Netherlands. The current CEO and founder details are not available.Syntarga.com specializes in providing innovative solutions that cater to a diverse client base across various sectors. The company’s core offerings include advanced technologies that enhance operational efficiency and streamline processes for businesses in industries such as logistics, manufacturing, and healthcare. These solutions are designed to address specific use cases, such as optimizing supply chain management and improving data analytics capabilities, thereby enabling organizations to make informed decisions and respond swiftly to market demands. Syntarga's products have been well-received in key geographical markets including North America and Europe, where they have successfully established partnerships with a range of clients, including multinational corporations and small to medium enterprises. The company’s focus on delivering tailored services ensures that a wide array of end users benefits from their innovative technologies.The revenue model of Syntarga.com is structured around a combination of subscription services and direct-to-consumer sales, which allows for both steady cash flow and the ability to engage directly with clients. Clients typically enter into agreements that include various pricing plans based on the scale and type of services utilized, including flagship products that are uniquely positioned in the market. The transactions often involve tiered subscription plans that accommodate varying levels of service and support, thus catering to businesses of all sizes. Additionally, Syntarga engages in direct sales for certain products, fostering strong relationships with its clients and ensuring tailored solutions are implemented effectively. Overall, the company’s revenue generation strategy exemplifies a commitment to providing value through its diverse product suite and direct engagement with clients.Syntarga B.V. is focused on expanding its product offerings and geographic presence. The company is working on launching new products tailored for the logistics and healthcare industries, with expected releases in the coming fiscal year. Additionally, Syntarga plans to enter new markets in Asia and South America by 2013. The funding from the deal in June 2011 will further support these initiatives, as the company seeks to enhance its technological capabilities and strengthen its client relationships.

## Funding rounds

- Series A, Apr 15, 2005 — Aglaia Oncology Funds, BioPartner Start-up Ventures

## Investors

- Aglaia Oncology Funds (https://capitalatlas.ai/funds/aglaia-oncology-funds) — Series A
- BioPartner Start-up Ventures (https://capitalatlas.ai/funds/biopartner-start-up-ventures) — Series A